Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Delirium × Dexmedetomidine × 1 year × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Pain, Postoperative 5 Breast Neoplasms 4 Thyroid Neoplasms 2 Chronic Pain 2 Brain Neoplasms 2 Agnosia 2 Urinary Bladder Neoplasms 1 Thrombosis 1 Sleep Initiation and Maintenance Disorders 1 Sigmoid Neoplasms 1 Sarcoma 1 Rectal Neoplasms 1 Pain 1 Opioid Consumption, Postoperative 1 Neuroinflammatory Diseases 1 Meningioma 1 Lung Injury 1 Inflammation 1 Hypoxia 1 Hyperthyroidism 1 Goiter 1 Elderly 1 Delirium 1 Colorectal Neoplasms 1 Breast Cancer Female 1 Abdominal Cancer Surgeries 1

Interventions

Saline Solution 2 Lorazepam 2 Haloperidol 2 suvorexant 1 remimazolam 1 haloperidol decanoate 1 Surveys and Questionnaires 1 Standard of Care 1 Propofol 1 Practice Guidelines as Topic 1 Interviews as Topic 1 Ibuprofen 1 Dexmedetomidine 1 Chlorpromazine 1 Acetaminophen 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07398066 2026-02-09

DEX-NEURO

University of Malaya

Phase NA Not yet recruiting

Brain Neoplasms, Delirium, Meningioma, Pain

Data powered by HemOnc (CC BY 4.0) Colophon ⚡